HERALD of North-Western State Medical University named after I.I. MechnikovHERALD of North-Western State Medical University named after I.I. Mechnikov2618-71162618-9704Eco-Vector1865610.17816/mechnikov202012163-70Research ArticlePathomorphological characteristics of myocardial infarction complicated by ruptureKovalchukE. Yu.povzun@rambler.ruPovzunA. S.<p>Associate Professor, MD, Head Physician</p>a.s.povzun@gmail.comSaint Petersburg Scientific Research Institute for Emergency Care named after I.I. DzhanelidzeFirst Saint Petersburg State Medical University named after academician I.P. Pavlov2805202012163701312201909042020Copyright © 2020, Повзун А.С., Povzun A.S.2020<p>The report presents the results of a pathoanatomical study of 81 cases of postinfarction cardiac rupture. The terms of development of cardiac rupture and comorbid background of patients are specified. Inconsistences of in vivo diagnostics of both ischemic heart disease and comorbid diseases, the results of autopsies were revealed.</p>myocardial infarctionpost-infarction cardiac rupturecomorbidityинфаркт миокардапостинфарктный разрыв сердцакоморбидность[Шор Г.В. О смерти человека (введение в танатологию). – Л.: КУБУЧ, 1925. – 254 с. [Shor GV. O smerti cheloveka (vvedenie v tanatologiyu). Leningrad: Izdatel’stvo KUBUCh; 1925. 254 p. (In Russ.)]][Нефедова Г.А. Особенности танатогенеза при остром инфаркте миокарда: Дис. … канд. мед. наук. – М., 2007. – 162 с. [Nefedova GA. Osobennosti tanatogeneza pri ostrom infarkte miokarda. [dissertation] Moscow; 2007. 162 p. (In Russ.)]][Рудакова Л.Е., Рахматуллов Ф.К., Бондаренко Л.А., и др. Предикторы разрыва сердца в остром периоде инфаркта миокарда (результаты ретроспективного исследования) // Известия высших учебных заведений. Поволжский регион. Медицинские науки. – 2009. – № 1. – С. 102–110. [Rudakova LE, Rakhmatullov FK, Bondarenko LA, et al. Prediktory razryva serdtsa v ostrom periode infarkta miokarda (rezul’taty retrospektivnogo issledovaniya). Izvestiia vysshikh uchebnykh zavedenii. Povolzhskii region. Meditsinskie nauki. 2009;(1):102-110. (In Russ.)]][Рудакова Л.Е., Фаткабрарова А.М., Бондаренко Л.А., и др. Тромболитическая терапия и разрывы сердца в остром периоде инфаркта миокарда // Известия высших учебных заведений. Поволжский регион. Медицинские науки. – 2012. – № 4. – С. 100–111. [Rudakova LE, Fatkabrarova AM, Bondarenko LA, et al. Tromboliticheskaya terapiya i razryvy serdtsa v ostrom periode infarkta miokarda. Izvestiia vysshikh uchebnykh zavedenii. Povolzhskii region. Meditsinskie nauki. 2012;(4):100-111. (In Russ.)]][Fornaro G, Lazzero M, Giacalone A, et al. Death after ST-elevation myocardial infarction in patients treated with fibrinolytic therapy, angioplasty, or conventional therapy. A post-mortem study to verify cardiac rupture as a cause of death. G Ital Cardiol (Rome). 2008;9(6):408-420.][Shamshad F, Kenchaiah S, Finn PV, et al. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT). Am Heart J. 2010;160(1):145-151. https://doi.org/10.1016/j.ahj.2010.02.037.][Пронина Е.Ю. Вершина айсберга: Эпидемиология ХОБЛ (Обзор литературы) // Вестник современной клинической медицины. – 2011. – Т. 4. – № 3. – С. 18–23. [Pronina EY. Top of the iceberg – epidemiology of COPD (Literature overview). Bulletin of contemporary clinical medicine. 2011;4(3):18-23. (In Russ.)]][Сигитова О.Н. Хроническая болезнь почек: современное состояние вопроса // Дневник Казанской медицинской школы. – 2013. – № 1. – С. 59–62. [Sigitova ON. Chronic the kidney disease current state the question. Dnevnik Kazanskoy meditsinskoy shkoly. 2013;(1):59-62. (In Russ.)]][Kang DG, Jeong MH, Ahn Y, et al. Clinical effects of hypertension on the mortality of patients with acute myocardial infarction. J Korean Med Sci. 2009;24(5):800-806. https://doi.org/10.3346/jkms.2009. 24.5.800.][Rembek M, Goch A, Goch J. The clinical course of acute ST-elevation myocardial infarction in patients with hypertension. Kardiol Pol. 2010;68(2):157-163.][Ali WM, Zubaid M, El-Menyar A, et al. The prevalence and outcome of hypertension in patients with acute coronary syndrome in six Middle-Eastern countries. Blood Press. 2011;20(1):20-26. https://doi.org/10.3109/ 08037051.2010.518673.][Cecchi E, D’Alfonso MG, Chiostri M, et al. Impact of hypertension history on short and long-term prognosis in patients with acute myocardial infarction treated with percutaneous angioplasty: comparison between STEMI and NSTEMI. High Blood Press Cardiovasc Prev. 2014;21(1):37-43. https://doi.org/10.1007/s40292-013-0032-1.][Landini L, Leone A. Effect of hypertension in heart rupture of acute myocardial infarction: clinico-pathological study. J Clin Hypertens. 2013;15(1):181.][Bucholz EM, Rathore SS, Reid KJ, et al. Body mass index and mortality in acute myocardial infarction patients. Am J Med. 2012;125(8):796-803. https://doi.org/ 10.1016/j.amjmed.2012.01.018.][Dhoot J, Tariq S, Erande A, et al. Effect of morbid obesity on in-hospital mortality and coronary revascularization outcomes after acute myocardial infarction in the United States. Am J Cardiol. 2013;111(8):1104-1110. https://doi.org/10.1016/j.amjcard.2012.12.033.][Niedziela J, Hudzik B, Niedziela N, et al. The obesity paradox in acute coronary syndrome: a meta-analysis. Eur J Epidemiol. 2014;29(11):801-812. https://doi.org/10.1007/s10654-014-9961-9.][Lavie CJ, Milani RV, Ventura HO. Impact of obesity on outcomes in myocardial infarction combating the “obesity paradox”. J Am Coll Cardiol. 2011;58(25):2651-2653. https://doi.org/10.1016/j.jacc.2011.09.032.][Sin DD. Is COPD really a cardiovascular disease? Chest. 2009;136(2):329-330. https://doi.org/10.1378/chest.09-0808.][Tonelli M, Muntner P, Lloyd A, et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study. Lancet. 2012;380(9844):807-814. https://doi.org/10.1016/s0140-6736(12)60572-8.][National Institute of Diabetes and Digestive and Kidney Diseases. Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda; 2012.][Miki T, Itoh T, Sunaga D, Miura T. Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning. Cardiovasc Diabetol. 2012;11:67. https://doi.org/10.1186/1475-2840- 11-67.][Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular Comorbidity in COPD. Chest. 2013;144(4):1163-1178. https://doi.org/10.1378/chest.12-2847.]